{"disease":{"id":"autoimmune-encephalitis","name":"autoimmune encephalitis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04806620","title":"Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Brain Inflammation Collaborative","has_results":false},{"nct_id":"NCT06443333","title":"National, Multicentric Registry Study on Neuroimmunological Diseases in China","phase":"","overall_status":"RECRUITING","enrollment_count":7000,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05198661","title":"Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis Collection","phase":"NA","overall_status":"RECRUITING","enrollment_count":3500,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07333196","title":"Tongji NADs Cohort","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1550,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06697678","title":"Risk Prediction Model for Severe Autoimmune Encephalitis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT04823728","title":"HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II","phase":"","overall_status":"UNKNOWN","enrollment_count":700,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03957616","title":"Incidence of Paraneoplastic Neurological Syndromes and Autoimmune Encephalitis","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05017142","title":"Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Bern","has_results":false},{"nct_id":"NCT05422664","title":"Acute Sympotomatic Seizure Secondary to Autoimmune Encephalitis and Autoimmune-associated Epilepsy","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Liu Yonghong","has_results":false},{"nct_id":"NCT05953974","title":"Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin","phase":"","overall_status":"UNKNOWN","enrollment_count":350,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07036042","title":"Clinical Characteristics of Patients With Anti-Collapsin Response Mediator Protein 2 Antibodies in Encephalitis or Encephalomyelitis","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT02905136","title":"Mechanisms of Auto-immune Encephalitis","phase":"","overall_status":"COMPLETED","enrollment_count":253,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05728931","title":"New Biomarkers in Auto-immune Encephalitis and Neurological Paraneoplastic Syndromes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":210,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07133113","title":"Medium-term Effects of Treatments in Autoimmune Encephalitis","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06760091","title":"A Multicentric Cohort of Autoimmune Encephalitis","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05772611","title":"Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04106596","title":"HLA Analysis in Autoimmune Encephalitis and Related Disorders","phase":"","overall_status":"UNKNOWN","enrollment_count":160,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05503264","title":"A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":152,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT04372615","title":"The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":116,"lead_sponsor_name":"University of Utah","has_results":false},{"nct_id":"NCT04708626","title":"Epidemiology of Autoimmune Encephalitides and Paraneoplastic Neurological Syndromes in Sweden","phase":"","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Uppsala University","has_results":false},{"nct_id":"NCT06019975","title":"FDG-PET in the Diagnosis of Autoimmune Encephalitis","phase":"","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"University of Milano Bicocca","has_results":false},{"nct_id":"NCT07145502","title":"Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Biocells Medical","has_results":false},{"nct_id":"NCT05280600","title":"Developing Advanced Neuroimaging for Clinical Evaluation of Autoimmune Encephalitis","phase":"","overall_status":"UNKNOWN","enrollment_count":75,"lead_sponsor_name":"King's College London","has_results":false},{"nct_id":"NCT05741619","title":"Long-term Follow up of Patient With Anti-GABAbr Antibodies Associated-encephalitis.","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03542279","title":"CPI Combination Therapy for Autoimmune Encephalitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT03194815","title":"IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of Cambridge","has_results":false},{"nct_id":"NCT06575153","title":"Phase 1 Study of ART5803 in Healthy Participants","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":64,"lead_sponsor_name":"Arialys Therapeutics","has_results":false},{"nct_id":"NCT06033846","title":"Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Xijing Hospital","has_results":false},{"nct_id":"NCT06173076","title":"A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Shen Chun-Hong","has_results":false},{"nct_id":"NCT06079294","title":"Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism","phase":"NA","overall_status":"RECRUITING","enrollment_count":56,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT05605223","title":"Study of Acute Autoimmune Encephalitis With Positive Antibodies in Eastern France","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"University Hospital, Strasbourg, France","has_results":false},{"nct_id":"NCT03993262","title":"Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT05825690","title":"BRIEF TITLE * (in English and Sufficiently Descriptive) Role of MRI in Anti-LGI1 Encephalitis","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05645185","title":"Characterisation of Clinical Phenotypes and Outcomes of Ma2 Patient","phase":"","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05177939","title":"Phase III Clinical Study of NPB-01 in Patients With Autoimmune Encephalitis","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Nihon Pharmaceutical Co., Ltd","has_results":false},{"nct_id":"NCT07131683","title":"hUC-MSC-Exo Therapy for Autoimmune Encephalitis","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT07337785","title":"CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Daishi Tian","has_results":false},{"nct_id":"NCT04561557","title":"Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT05783947","title":"Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies","phase":"","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07093333","title":"A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Antibody-Associated Psychiatric Disease","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Arialys Australia Pty Ltd","has_results":false},{"nct_id":"NCT07158229","title":"Long-term Impact of NMDAR Encephalitis, Level 3","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06432803","title":"Metabolic Imaging for Diagnosis and Prognostication of Autoimmune encephalitiS","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06245447","title":"Brain MRI Longitudinal Volumetric Characteristics Associated With Outcomes of CASPR2-Limbic Encephalitis","phase":"","overall_status":"UNKNOWN","enrollment_count":27,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04175522","title":"Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"Green Cross Corporation","has_results":false},{"nct_id":"NCT03530462","title":"To Explore Cognitive Neural Mechanism of Autoimmune Encephalitis by Using Neuropsychological Tests and Multi-modal MRI","phase":"","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT07477015","title":"Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT06609044","title":"Long-term Impact of NMDAR Encephalitis","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04339127","title":"Autoimmune Encephalitis With Anti-NMDA Receptor Antibodies Following Herpetic Encephalitis","phase":"","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT04875975","title":"A Study to Test the Efficacy, Safety, and Pharmacokinetics of Rozanolixizumab in Adult Study Participants With Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT06753955","title":"Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":6,"lead_sponsor_name":"Arialys Therapeutics","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}